B. Brockmann

724 total citations
21 papers, 609 citations indexed

About

B. Brockmann is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, B. Brockmann has authored 21 papers receiving a total of 609 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in B. Brockmann's work include Cancer Treatment and Pharmacology (5 papers), Advanced Breast Cancer Therapies (2 papers) and Photosynthetic Processes and Mechanisms (2 papers). B. Brockmann is often cited by papers focused on Cancer Treatment and Pharmacology (5 papers), Advanced Breast Cancer Therapies (2 papers) and Photosynthetic Processes and Mechanisms (2 papers). B. Brockmann collaborates with scholars based in Germany, United Kingdom and United States. B. Brockmann's co-authors include Manuela Elsen, Jürgen Eckel, A.S. Lübbe, Ch. Bergemann, Frode Norheim, Mark Sommerfeld, Arnt Erik Tjønna, Johann Gassenhuber, Truls Raastad and Jostein Hallén and has published in prestigious journals such as PLoS ONE, Journal of Bacteriology and Journal of Magnetism and Magnetic Materials.

In The Last Decade

B. Brockmann

19 papers receiving 589 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Brockmann Germany 11 301 206 142 93 71 21 609
Mingming Chen China 15 171 0.6× 507 2.5× 58 0.4× 60 0.6× 109 1.5× 38 836
Mayumi Tamura Japan 16 198 0.7× 489 2.4× 78 0.5× 43 0.5× 56 0.8× 48 817
Joseph C. Yawe United States 9 359 1.2× 299 1.5× 480 3.4× 17 0.2× 41 0.6× 9 976
Luisa Benassi Italy 18 42 0.1× 282 1.4× 42 0.3× 55 0.6× 61 0.9× 36 740
Dawn A. Delfín United States 15 63 0.2× 347 1.7× 141 1.0× 37 0.4× 44 0.6× 21 641
Xinyu Ma China 13 47 0.2× 288 1.4× 119 0.8× 27 0.3× 77 1.1× 45 685
Yingying Liu China 15 79 0.3× 574 2.8× 56 0.4× 11 0.1× 50 0.7× 36 826
Ronny Mohren Netherlands 11 139 0.5× 185 0.9× 50 0.4× 12 0.1× 60 0.8× 24 396
William J. Stanley Australia 10 241 0.8× 294 1.4× 82 0.6× 5 0.1× 57 0.8× 16 680
Eduardo Fernández-Segura Spain 12 124 0.4× 229 1.1× 39 0.3× 8 0.1× 17 0.2× 28 514

Countries citing papers authored by B. Brockmann

Since Specialization
Citations

This map shows the geographic impact of B. Brockmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Brockmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Brockmann more than expected).

Fields of papers citing papers by B. Brockmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Brockmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Brockmann. The network helps show where B. Brockmann may publish in the future.

Co-authorship network of co-authors of B. Brockmann

This figure shows the co-authorship network connecting the top 25 collaborators of B. Brockmann. A scholar is included among the top collaborators of B. Brockmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Brockmann. B. Brockmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Raschke, Silja, Manuela Elsen, Johann Gassenhuber, et al.. (2013). Evidence against a Beneficial Effect of Irisin in Humans. PLoS ONE. 8(9). e73680–e73680. 270 indexed citations
4.
Brockmann, B., et al.. (2013). Time-Delayed In Vivo Assembly of Subunit a into Preformed Escherichia coli FoF1 ATP Synthase. Journal of Bacteriology. 195(18). 4074–4084. 11 indexed citations
5.
Dahlman, Ingrid, Manuela Elsen, Norbert Tennagels, et al.. (2012). Functional annotation of the human fat cell secretome. Archives of Physiology and Biochemistry. 118(3). 84–91. 89 indexed citations
6.
Brockmann, B., M. W. Smith, Andrey G. Zaraisky, et al.. (2001). Subcellular Localization and Targeting of Glucocorticoid Receptor Protein Fusions Expressed in Transgenic Arabidopsis thaliana. Plant and Cell Physiology. 42(9). 942–951. 14 indexed citations
7.
Bergemann, Ch., et al.. (2001). Comparison of different particles and methods for magnetic isolation of circulating tumor cells. Journal of Magnetism and Magnetic Materials. 225(1-2). 175–179. 89 indexed citations
8.
Min, Xiang Jia, Kazunori Okada, B. Brockmann, Tomokazu Koshiba, & Yuji Kamiya. (2000). Molecular cloning and expression patterns of three putative functional aldehyde oxidase genes and isolation of two aldehyde oxidase pseudogenes in tomato. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1493(3). 337–341. 32 indexed citations
9.
Brockmann, B., et al.. (1994). [Prognostic factors of metastatic breast cancer--2].. PubMed. 88(4). 305–9.
10.
Brockmann, B. & P Reitzig. (1994). ["Prognostic factors" in breast cancer--1].. PubMed. 88(2). 111–4.
11.
Back, D.J., et al.. (1993). Effect of chlormethiazole on hepatic monooxygenases activity in vivo. European Journal of Clinical Pharmacology. 44(2). 203–204. 4 indexed citations
12.
Brockmann, B.. (1992). [Therapy of the recurrence of malignant lymphoma].. PubMed. 86(17). 843–6. 3 indexed citations
13.
Brockmann, B., et al.. (1992). Characterization of an extracellular β-1,3-glucanase of Claviceps purpurea. Physiological and Molecular Plant Pathology. 40(3). 191–201. 16 indexed citations
14.
Schmidt, U., et al.. (1991). Ergebnisse der Hormontherapie mit Aminoglutethimid (Rodazol®) beim Postmenopausalen metastasierten Mammakarzinom. Geburtshilfe und Frauenheilkunde. 51(4). 276–279. 1 indexed citations
15.
16.
Brockmann, B., et al.. (1989). [Therapeutic results and toxic side effects of the combination cytostasan, adriamycin and vincristine as second-line therapy of metastatic breast cancer].. PubMed. 59(5). 341–6. 4 indexed citations
17.
Preiß, Rainer, et al.. (1987). Pharmacokinetics of adriamycin, adriamycinol, and antipyrine in patients with moderate tumor involvement of the liver. Journal of Cancer Research and Clinical Oncology. 113(6). 593–598. 17 indexed citations
18.
Preiß, Rainer, et al.. (1985). [The pharmacokinetics of bendamustine (Cytostasane) in humans].. PubMed. 40(11). 782–4. 25 indexed citations
19.
Preiß, Rainer, et al.. (1985). Plasma pharmacokinetics of adriamycin and antipyrine and its relation to the therapeutic and toxic effects.. PubMed. 23 Suppl 1. S79–88. 2 indexed citations
20.
Sohr, Reinhard, et al.. (1984). Untersuchungen zur Bioverfügbarkeit von Cyclophosphamid nach peroraler Applikation im hohen Dosisbereich. Oncology Research and Treatment. 7(1). 48–49. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026